skip to primary navigationskip to content

Postdoc Opportunity in Synthetic Biology in the Department of Bioengineering at Imperial College London

This challenging and innovative project aims at manipulating microorganisms in order to create synthetic communities or ecosystems with enhanced capacities for bioproduction and biotechnology. The project will combine the creation of novel synthetic biology tools to generate emergent behaviours at population level as well as their use for industrial applications. The project is BBSRC funded for 36 months, and we are aiming to start by 20th August.

postdocimperial

Expression of interest for candidates  

Please contact us if you are a highly motivated postdoc researcher who is excited about synthetic biology and microbial biotechnology and would be interested in joining this project. We plan to soon officially advertise the post for this project, but in the meantime, please contact Dr Rodrigo Ledesma-Amaro for informal discussions. Preferred expertise includes previous works on synthetic biology, metabolic engineering, microbial biotechnology, microbiology, molecular biology, or microbial communities, but additional skills are welcome (e.g. theoretical/computational). 

Contact Dr Ledesma-Amaro by email with your CV at

The group and the working environment 

Rodrigo Ledesma-Amaro (http://www.imperial.ac.uk/people/r.ledesma-amaro) is a group leader of young, dynamic and growing research group at Imperial College London working at the interface between synthetic biology and metabolic engineering with applications in biotechnology, biomedicine and biomaterials. The group works closely with Dr Tom Ellis (http://www.tomellislab.com/) and Dr Guy-Bart Stan (http://www.bg.ic.ac.uk/research/g.stan/group/research.shtml) and has regular interactions and communications with many biotech companies as well. 

Filed under:

About

The Synthetic Biology Strategic Research Initiative provides a hub for anyone interested in Synthetic Biology at the University of Cambridge, including researchers, commercial partners and external collaborators.